PSA response to cabazitaxel is associated with improved progression-free survival in metastatic castration-resistant prostate cancer: the non-interventional QoLiTime study
To evaluate the association between prostate-specific antigen (PSA) response and progression-free and overall survival in men with metastatic castration-resistant prostate cancer (mCRPC) treated with cabazitaxel.
Gespeichert in:
| Hauptverfasser: | , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
5 January 2018
|
| In: |
World journal of urology
Year: 2018, Jahrgang: 36, Heft: 3, Pages: 375-381 |
| ISSN: | 1433-8726 |
| DOI: | 10.1007/s00345-017-2138-x |
| Online-Zugang: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1007/s00345-017-2138-x
|
| Verfasserangaben: | Peter Hammerer, Salah-Eddin Al-Batran, Christine Windemuth-Kieselbach, Martin Keller, Ralf-Dieter Hofheinz |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1700648632 | ||
| 003 | DE-627 | ||
| 005 | 20220818122241.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 200616s2018 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1007/s00345-017-2138-x |2 doi | |
| 035 | |a (DE-627)1700648632 | ||
| 035 | |a (DE-599)KXP1700648632 | ||
| 035 | |a (OCoLC)1341339695 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Hammerer, Peter |e VerfasserIn |0 (DE-588)1187977349 |0 (DE-627)1666937630 |4 aut | |
| 245 | 1 | 0 | |a PSA response to cabazitaxel is associated with improved progression-free survival in metastatic castration-resistant prostate cancer |b the non-interventional QoLiTime study |c Peter Hammerer, Salah-Eddin Al-Batran, Christine Windemuth-Kieselbach, Martin Keller, Ralf-Dieter Hofheinz |
| 264 | 1 | |c 5 January 2018 | |
| 300 | |a 7 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 16.06.2020 | ||
| 520 | |a To evaluate the association between prostate-specific antigen (PSA) response and progression-free and overall survival in men with metastatic castration-resistant prostate cancer (mCRPC) treated with cabazitaxel. | ||
| 700 | 1 | |a Hofheinz, Ralf-Dieter |d 1969- |e VerfasserIn |0 (DE-588)121917517 |0 (DE-627)08161876X |0 (DE-576)292991568 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t World journal of urology |d Berlin : Springer, 1983 |g 36(2018), 3, Seite 375-381 |h Online-Ressource |w (DE-627)254910874 |w (DE-600)1463303-6 |w (DE-576)074754505 |x 1433-8726 |7 nnas |a PSA response to cabazitaxel is associated with improved progression-free survival in metastatic castration-resistant prostate cancer the non-interventional QoLiTime study |
| 773 | 1 | 8 | |g volume:36 |g year:2018 |g number:3 |g pages:375-381 |g extent:7 |a PSA response to cabazitaxel is associated with improved progression-free survival in metastatic castration-resistant prostate cancer the non-interventional QoLiTime study |
| 856 | 4 | 0 | |u https://doi.org/10.1007/s00345-017-2138-x |x Verlag |x Resolving-System |z lizenzpflichtig |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20200616 | ||
| 993 | |a Article | ||
| 994 | |a 2018 | ||
| 998 | |g 121917517 |a Hofheinz, Ralf-Dieter |m 121917517:Hofheinz, Ralf-Dieter |d 60000 |d 61200 |e 60000PH121917517 |e 61200PH121917517 |k 0/60000/ |k 1/60000/61200/ |p 5 |y j | ||
| 999 | |a KXP-PPN1700648632 |e 3687458768 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"language":["eng"],"title":[{"title":"PSA response to cabazitaxel is associated with improved progression-free survival in metastatic castration-resistant prostate cancer","subtitle":"the non-interventional QoLiTime study","title_sort":"PSA response to cabazitaxel is associated with improved progression-free survival in metastatic castration-resistant prostate cancer"}],"person":[{"role":"aut","given":"Peter","display":"Hammerer, Peter","family":"Hammerer"},{"family":"Hofheinz","given":"Ralf-Dieter","role":"aut","display":"Hofheinz, Ralf-Dieter"}],"name":{"displayForm":["Peter Hammerer, Salah-Eddin Al-Batran, Christine Windemuth-Kieselbach, Martin Keller, Ralf-Dieter Hofheinz"]},"relHost":[{"title":[{"title_sort":"World journal of urology","title":"World journal of urology"}],"part":{"year":"2018","text":"36(2018), 3, Seite 375-381","volume":"36","extent":"7","pages":"375-381","issue":"3"},"language":["eng"],"pubHistory":["1.1983 -"],"disp":"PSA response to cabazitaxel is associated with improved progression-free survival in metastatic castration-resistant prostate cancer the non-interventional QoLiTime studyWorld journal of urology","id":{"zdb":["1463303-6"],"issn":["1433-8726"],"eki":["254910874"]},"physDesc":[{"extent":"Online-Ressource"}],"note":["Gesehen am 06.12.05","Teils ungezählte Beil.: Supplement"],"type":{"bibl":"periodical","media":"Online-Ressource"},"recId":"254910874","origin":[{"dateIssuedKey":"1983","dateIssuedDisp":"1983-","publisher":"Springer","publisherPlace":"Berlin ; Heidelberg"}]}],"note":["Gesehen am 16.06.2020"],"id":{"doi":["10.1007/s00345-017-2138-x"],"eki":["1700648632"]},"physDesc":[{"extent":"7 S."}],"recId":"1700648632","origin":[{"dateIssuedKey":"2018","dateIssuedDisp":"5 January 2018"}],"type":{"bibl":"article-journal","media":"Online-Ressource"}} | ||
| SRT | |a HAMMERERPEPSARESPONS5201 | ||